Product
VC005
Aliases
VC005 tablets, VC005 Tablets Placebo
5 clinical trials
4 indications
Indication
Atopic DermatitisIndication
Rheumatoid ArthritisIndication
Inflammatory Bowel DiseaseIndication
Ankylosing SpondylitisClinical trial
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase II Clinical Study to Evaluate the Efficacy and Safety of VC005 Tablets in Adult Patients With Moderate to Severe Atopic DermatitisStatus: Recruiting, Estimated PCD: 2026-08-23
Clinical trial
A Randomized, Double-blind, Dose-escalating, Placebo-controlled Phase Ib Clinical Study of VC005 Tablets in Subjects With Rheumatoid Arthritis.Status: Completed, Estimated PCD: 2023-10-18
Clinical trial
Safety, Tolerance and Pharmacokinetics Clinical Study of VC005 in Healthy Subjects and Patients With Mild to Moderate Atopic DermatitisStatus: Recruiting, Estimated PCD: 2024-12-30
Clinical trial
Randomized, Double-blind, Multiple-dose Escalation, Placebo-controlled Phase I Clinical Study to Evaluate the Tolerance, Pharmacokinetics and Pharmacodynamics of VC005 Tablets in Healthy SubjectsStatus: Completed, Estimated PCD: 2022-11-02
Clinical trial
A Multicenter, Randomized, Double-blind, Controlled Phase II Clinical Study to Evaluate the Efficacy and Safety of VC005 Tablets in Subjects With Active Ankylosing Spondylitis.Status: Recruiting, Estimated PCD: 2026-04-23